Rapid Diagnosis of Severe Respiratory Tract Infectious Diseases and Screening of Biomarkers for Stratified Diagnosis

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06533514

Enrollment

100

Registered

2024-08-01

Start date

2024-09-01

Completion date

2025-12-01

Last updated

2024-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biomarkers, Severe Pneumonia

Brief summary

The purpose of this study is to clarify the biomarkers for rapid diagnosis and stratified diagnosis of severe respiratory tract infectious diseases through clinical experiments.

Detailed description

Methods: The relationship between relevant biomarkers and stratified diagnosis was analyzed by collecting laboratory and etiological examinations of patients with severe pneumonia.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Meets the diagnostic criteria for severe pneumonia； * Age≥18 years old and \< 80 years old； * Willing to sign informed consent for the course of the study；

Exclusion criteria

* Patients with intracranial hypertension, acute coronary syndrome, pleural fistula, pneumothorax, or subcutaneous emphysema; * Pregnant and lactating patients; * Severely hemodynamically unstable (an increase in vasopressors by more than 30% in the first 6 hours, or norepinephrine \>0.5mg/kg/min); * Those who do not consent to participate in this study；

Design outcomes

Primary

Measure	Time frame	Description
The relationship between the patient's specific biomarker levels and clinical outcomes.	1 mounth	Treatment failure rate, Mortality rates, SOFA rating scale

Contacts

Primary Contactfei xie, doctor

xiefei0522@163.com13911385976

Outcome results